Syner-G

SEPTEMBER 20, 2023

pharmaceutical company to oversee a 6 month, DS manufacturing as Person-In- Plant (PIP) and assist with preparation of associated submission documents related to Phase III clinical trial batches. Download The Case Study The post Process improvements and in-person monitoring help U.S.

Process Improvement 40

Process Improvement Pharmaceutical Companies Pharmaceutical Companies Documentation 40

Drug Patent Watch

DECEMBER 12, 2024

Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceutical Companies Biosimilars Drug Development 96

Express Pharma

AUGUST 9, 2024

This involves identifying critical quality attributes and process parameters and implementing strong controls for consistent product quality. Supply chain management: Pharmaceutical companies should focus on building resilient and flexible supply chains capable of adapting to market fluctuations and disruptions.

Inventory Control 105

Inventory Control Customer Service Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

NOVEMBER 9, 2023

To ensure an efficient process, MyMD works closely with the contract manufacturing organisation (CMO) focusing on automation and process improvement. All pharmaceutical companies want to save on the cost of production, but not at the expense of quality. This allows us to stay on top of quality control.

Drug Development 115

Drug Development Immunization Immunity Pharmaceutical Companies 115

PharmaState Academy

OCTOBER 20, 2023

a) Maximizing Profits through maximum patient's care b) Putting Patients First c) Regulatory Compliance and patient outcome d) Internal Processes improvement to improve patient's health outcomes 5 / 20 How can patient-centric marketing contribute to better healthcare outcomes?

Dosage 59

Dosage Pharmaceutical Companies Pharmaceutical Companies Process Improvement 59

European Pharmaceutical Review

JANUARY 27, 2025

The emergence of huge pharmaceutical companies with discrete centres of excellence in geographically dispersed locations has upended the classic model of one-stop shopping for all development functions. An example of the structured and modular tech transfer approach is shown in Figure 2.

Communication 52

Communication Documentation Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

JULY 10, 2024

Biswas outlines, “Adopting advanced manufacturing technologies, including continuous processing, digitally programmed manufacturing systems (MES) and deep learning based continuous process improvements are factors that hold immense promise for transforming biopharma production.

Vaccines 96

Vaccines Drug Development Process Improvement Biosimilars 96